a developer of next generation products based on the transformative potential of gene therapy
Industry Biotechnology
A.I.dvisor indicates that over the last year, BLUE has been loosely correlated with NTLA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BLUE jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To BLUE | 1D Price Change % | ||
---|---|---|---|---|
BLUE | 100% | +1.03% | ||
NTLA - BLUE | 49% Loosely correlated | -3.65% | ||
BEAM - BLUE | 46% Loosely correlated | -8.55% | ||
ARGX - BLUE | 46% Loosely correlated | -0.60% | ||
EDIT - BLUE | 45% Loosely correlated | -6.68% | ||
CRSP - BLUE | 45% Loosely correlated | -4.61% | ||
More |
Ticker / NAME | Correlation To BLUE | 1D Price Change % |
---|---|---|
BLUE | 100% | +1.03% |
biotechnology theme (248 stocks) | 43% Loosely correlated | +5.56% |
gene therapy theme (13 stocks) | 30% Poorly correlated | +1.26% |
transformative theme (4 stocks) | 27% Poorly correlated | +2.30% |